Snowden Capital Advisors LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 83 filers reported holding ENZO BIOCHEM INC in Q1 2021. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
Snowden Capital Advisors LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$30,099
-27.9%
21,499
-5.3%
0.00%0.0%
Q2 2023$41,766
-23.6%
22,699
+0.9%
0.00%
-50.0%
Q1 2023$54,673
+31.4%
22,499
-22.7%
0.00%0.0%
Q4 2022$41,619
-40.5%
29,104
-8.2%
0.00%
-33.3%
Q3 2022$70,000
+2.9%
31,704
-4.1%
0.00%0.0%
Q2 2022$68,000
-34.6%
33,054
-8.3%
0.00%
-25.0%
Q1 2022$104,000
+9.5%
36,054
+21.6%
0.00%
-20.0%
Q4 2021$95,000
-4.7%
29,649
-5.7%
0.01%0.0%
Q2 2021$99,693
-9.0%
31,449
-1.3%
0.01%
-16.7%
Q1 2021$109,561
+40.3%
31,849
+2.7%
0.01%
+20.0%
Q4 2020$78,117
+25.9%
30,999
+5.4%
0.01%0.0%
Q3 2020$62,032
-0.4%
29,399
+5.8%
0.01%0.0%
Q2 2020$62,270
+5.0%
27,799
+18.5%
0.01%
-16.7%
Q1 2020$59,329
+14.8%
23,450
-98.8%
0.01%
+50.0%
Q4 2019$51,680
-28.4%
1,965,000
-2.0%
0.00%
-42.9%
Q3 2019$72,212
+61.2%
2,005,900
+12124.4%
0.01%
+40.0%
Q1 2019$44,797
+16.7%
16,409
+18.8%
0.01%0.0%
Q4 2018$38,389
-7.8%
13,809
+36.6%
0.01%0.0%
Q3 2018$41,64910,1090.01%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders